Tag: janssen
Janssen seeks approval for rivaroxaban to be used to reduce cardiac events
Janssen has submitted a supplemental new drug application to the US FDA for two new indications ...
COMPASS study of rivaroxaban to end early for efficacy
The phase three COMPASS trial, evaluating the efficacy and safety of rivaroxaban (Xarelto, Bayer) fo...
